Raily Aesthetic Medicine International Holdings Limited
HKSE: 2135.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Jianliang Song
- Employees
- 290
- Headquarters
- Hangzhou, China
- IPO year
- 2020
- Market cap
- HK$80.2M
- Website
- https://www.raily.com
Loading 2135…
Loading profile data…Frequently asked questions about 2135
What does Raily Aesthetic Medicine International Holdings Limited (2135.HK) do?
Raily Aesthetic Medicine International Holdings Limited, an investment holding company, provides aesthetic medical services. The company operates through three segments: Aesthetic Medical Services, Consulting Services, and Aesthetic Medical Equipment Products. Its services include aesthetic surgery services, including aesthetic surgical procedur...
Where does 2135.HK trade?
Raily Aesthetic Medicine International Holdings Limited (2135.HK) trades on the Hong Kong Stock Exchange.
What sector is 2135.HK in?
Raily Aesthetic Medicine International Holdings Limited (2135.HK) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Raily Aesthetic Medicine International Holdings Limited?
Jianliang Song is the chief executive officer of Raily Aesthetic Medicine International Holdings Limited (2135.HK).
Where is Raily Aesthetic Medicine International Holdings Limited headquartered?
Raily Aesthetic Medicine International Holdings Limited is headquartered in China.
Does 2135.HK pay a dividend?
Raily Aesthetic Medicine International Holdings Limited (2135.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 2135.HK go public?
Raily Aesthetic Medicine International Holdings Limited (2135.HK) completed its initial public offering in 2020.